Advances in Nanotechnology Development to Overcome Current Roadblocks in CAR-T Therapy for Solid Tumors

Chimeric antigen receptor T cell (CAR-T) therapy for the treatment of hematologic tumors has achieved remarkable success, with five CAR-T therapies approved by the United States Food and Drug Administration. However, the efficacy of CAR-T therapy against solid tumors is not satisfactory. There are t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Juan, Ye, Qing, Min, Yuanzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983935/
https://www.ncbi.nlm.nih.gov/pubmed/35401561
http://dx.doi.org/10.3389/fimmu.2022.849759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983935/
https://www.ncbi.nlm.nih.gov/pubmed/35401561
http://dx.doi.org/10.3389/fimmu.2022.849759

Ejemplares similares